Elevated IL-17 production triggers and sustains PC immunosuppression by recruiting neutrophils and excluding cytotoxic CD8+ T cells from tumors and renders PC resistant to checkpoint immunotherapy [96]. Here, IL17A is linked to pachyonychia congenita.